Return to Vaccination News Home Page
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
Vaccine
Volume 21, Issues 21-22 , 20 June 2003, Pages 2948-2953
| This Document | ||
|
|
Abstract | |
| Full Text + Links | ||
| PDF (234 K) | ||
| Actions | ||
| E-mail Article | ||
![]()
doi:10.1016/S0264-410X(03)00113-0
Cite
or link using doi
Copyright © 2003 Elsevier Science Ltd. All rights reserved.
Immunity against measles in populations of women and infants in Poland
Wieslawa Janaszek
,
and Janusz Slusarczyk
During the 1997–1998 measles epidemic in Poland a high attack rate occurred in infants up to 1 year of age (24.6/100,000 in comparison with 5.5/100,000 in total population). Routine vaccination against measles for infants aged 13–15 months was introduced in Poland in 1975, and a second dose added in 1991. The recommended age for measles vaccination was based on information gathered in years when most mothers had a natural measles. Nowadays, many mothers have received measles vaccine.
Early loss of passively acquired measles antibody may occur in infants of women who received measles vaccine, because measles vaccine induces lower antibody titres than does natural infection.
Therefore, measles-specific antibody titres were determined among vaccinated and unvaccinated women as well as among infants, whose mothers were born after 1976 and likely were vaccinated (Group 1), and those, whose mothers were born before 1969 and likely have had a natural measles (Group 2). All women that were born in prevaccination era had significantly higher geometric mean titre (GMT) of measles antibody than those who were vaccinated (P<0.001).
Also infants from Group 2 at every age had higher GMT of measles antibody than those of Group 1. The antibody decay was significantly faster among infants whose mothers acquired immunity by measles vaccination. Because nowadays the majority of women in childbearing age are vaccinated against measles, earlier vaccination in the infants should be considered.
Author Keywords: Measles; Passive immunity;
Vaccination
|
|
|||||||||||||||||||||||||
Vaccine |
|||||||||||||||||||||||||
| 35 of 53 |
|
|
|
|
| Send
feedback to ScienceDirect Software and compilation © 2003 ScienceDirect. All rights reserved. ScienceDirect® is an Elsevier Science B.V. registered trademark. |
Your use of this service is
governed by
Terms and Conditions. Please review our
Privacy Policy for details on how we protect information that
you supply.
Return to Vaccination News Home Page
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.